Control Bionics (ASX: CBL) has implemented Apple’s new Brain–Computer Interface (BCI) protocol across its product range, marking a major step forward in making assistive communication technology more seamless and intuitive for people living with severe speech and physical impairments.
The integration will be applied to the company’s NeuroNode and NeuroNode Trilogy systems, which enable users to control computers and mobile devices through neural and motion-based input.
By adopting Apple’s BCI protocol, Control Bionics said it can now deliver faster setup, improved neural signal feedback, and instant device activation across iOS platforms.
Next-Gen Assistive Functionality
The NeuroNode technology detects minute electrical signals from the brain to muscles, translating them into computer commands that allow users to type, speak or navigate digital environments.
The Apple BCI protocol allows users to interact with iPhones and iPads using the same neural signals, streamlining accessibility and reducing setup complexity for those reliant on assistive communication systems.
The upgrade provides three core benefits: simplified device pairing, real-time visual feedback within iOS for neural connection strength, and automatic activation of Switch Control when the device connects or wakes.
Control Bionics said these improvements would remove barriers for both users and caregivers by enabling a true plug-and-play experience, while enhancing connection stability and performance in daily use.
Chief executive officer Jeremy Steele said the integration “marks a defining moment for Control Bionics and for AAC innovation globally,” adding that it would allow the company to “deliver a truly integrated neural-control experience within iOS — reducing setup friction, improving signal monitoring, and making communication faster and more intuitive.”
Initial Beta Rollout
Control Bionics is rolling out the enhanced functionality to existing customers in beta form, providing feedback to Apple to help refine the protocol ahead of broader release.
An early user in Melbourne described the integration as “life changing,” noting that the new visual neuro-feedback makes it easier to operate the system independently.
The company is well positioned to bring these advances to market, with thousands of active users worldwide, as well as established funding frameworks through the US Medicare HCPCS reimbursement system and Australia’s National Disability Insurance Scheme.
The adoption of Apple’s BCI interface should strengthen Control’s footprint across the US, Australia, and international assistive technology markets.
The company said the collaboration reinforces its mission to provide people with disabilities the fastest, simplest, and most reliable path to communication and independence.
